Acceder

Publicaciones - ONCOLOGÍA CLÍNICA Y TRASLACIONAL

Cargando...
Marquez-Rodas I, Dutriaux C, Saiag P, de la Cruz Merino L, Castanon Alvarez E, Robert C, Rodriguez-Moreno JF, Arance A, Cerezuela-Fuentes P, Montaudie H, Sanmamed MF, Gonzalez-Cao M, Charles J, Lopez Criado MP, Berrocal A, de Miguel E, Funck-Brentano E, Prey S, Alamo de la Gala MC, Melero I, Aviles-Izquierdo JA, Roman R, Garcia-Pelaez B, Rodriguez S, Trnkova ZJ, Quintero M, Macia S, Chaney MF, Dalle S. BO-112 Plus Pembrolizumab for Patients With Anti-PD-1-Resistant Advanced Melanoma: Phase II Clinical Trial SPOTLIGHT-203. J Clin Oncol. 2025 Jun 27:JCO2402595. doi: 10.1200/JCO-24-02595. Online ahead of print. PubMed PMID: 40577656.
AÑO: 2025; IF: 42.1
Lopez-Miranda E, Perez-Garcia JM, Gion M, Ribelles N, Cortez-Castedo P, Alonso-Romero JL, Garcia MM, Gonzalez-Santiago S, Bermejo B, Morales S, Caranana V, Garrigos L, Fernandez-Pinto M, Garcia-Vicente S, Garcia-Sanz A, Mena-Molina A, Boix O, Alcala-Lopez D, Llombart-Cussac A, Cortes J. Ipatasertib combined with non-taxane chemotherapy for patients with previously treated advanced triple-negative breast cancer: the PATHFINDER phase IIa trial. Breast Cancer Res. 2025 Aug 6;27(1):141. doi: 10.1186/s13058-025-02089-4. PubMed PMID: 40770648; PubMed Central PMCID: PMC12326808.
AÑO: 2025; IF: 6.1
Agrawal YN, Fernandez-Martinez A, Gil-Gil M, Zielinski C, Ruiz-Borrego M, Ciruelos EM, Munoz M, Margeli M, Bermejo B, Anton A, Kahan Z, Csoszi T, Alonso-Romero JL, Garcia-Saenz JA, Sanchez-Rovira P, Alvarez E, Chacon JI, Gonzalez-Santiago S, Rodriguez CA, Servitja S, Pfefferle AD, Herranz J, Liu Y, Carey LA, Romero-Camarero I, Caballero R, Guerrero-Zotano A, Perou CM, Martin M. Transcriptomic Predictors of Survival for Palbociclib + Endocrine Therapy Versus Capecitabine in Aromatase Inhibitor-Resistant Breast Cancer From the GEICAM/2013-02 PEARL Trial. JCO Precis Oncol. 2025 Jul;9:e2400937. doi: 10.1200/PO-24-00937. Epub 2025 Jul 9. PubMed PMID: 40632974; PubMed Central PMCID: PMC12261110.
AÑO: 2025; IF: 5.3
Encarnacion JA, Morillo Macias V, De la Fuente Munoz I, Soria VD, Fernandez Fornos L, Antequera MA, Rey OA, Garcia Martinez V, Alonso-Romero JL, Garcia Gomez R. Apalutamide and Stereotactic Body Radiotherapy in Metastatic Hormone-Sensitive Prostate Cancer: Multicenter Real-World Study. Cancers (Basel). 2025 Jul 2;17(13):2216. doi: 10.3390/cancers17132216. PubMed PMID: 40647514; PubMed Central PMCID: PMC12249003.
AÑO: 2025; IF: 4.5
Encarnacion JA, Hernandez AL, Lopez GL, Alonso-Romero JL, De la Fuente Munoz MI, Canovas EC, Carreno PR, Royo-Villanova M, Manso C. Probable chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids syndrome: management with corticosteroids and intravenous immunoglobulin-a case report. J Med Case Rep. 2025 Jul 17;19(1):351. doi: 10.1186/s13256-025-05402-z. PubMed PMID: 40676639; PubMed Central PMCID: PMC12272981.
AÑO: 2025
Siguiente >

Instituto de Investigación Sanitaria Acreditado

ISCII